VST · Vistra Corp. · Stock research

Current Thesis

The frame carried through July was a de-rate on multiple compression while the demand inputs strengthened. The week of 2026-08-03 put that to a direct test, because three merchant peers reported before Vistra did. The numbers came back better than the tape.

NRG reported 08-04: Q2 adjusted EBITDA $1,217M (+34% YoY), GAAP net income $506M, revenue $7.481B, FY26 guidance reaffirmed, plus a planned 1.2 GW combined-cycle build in Texas for a hyperscaler targeting $500M of annual EBITDA. The shares fell 15.48% to $117.04, with Reuters attributing the adjusted-profit miss to higher interest costs. Talen released after the 08-05 close — $374M Q2 adjusted EBITDA, $212M adjusted FCF, 2026 guidance raised — and rose 2.57% to $338.31 the next session. Constellation's 08-06 release lifted FY26 adjusted operating EPS guidance to $11.50–12.50 from $11.00–12.00, put Q2 at $2.55 against $1.91 a year earlier, and disclosed roughly 920 MW of new long-term nuclear PPAs at 18.5-year average duration including Walmart's first; CEG closed that session down 1.52% at $261.10.

Vistra's own tape was worse than the group's. On 08-04 it fell 8.15% to $143.23 on 11.44M shares — the heaviest volume of the stretch, and more than three times the largest peer decline that day (CEG -2.36%, TLN -1.30%) — with no company release. On 08-05 it closed $140.58, forfeiting the 07-29 flush low of $142.81. On 08-06 it closed $141.38. The 08-03 group bounce to $155.94 is entirely gone.

What an investor is buying here is the second-order AI-power leg: PJM and ERCOT scarcity pricing converting into merchant earnings the company has not yet sold forward, with a new 2026 capacity event dated 09-30. What the tape says is that the market has stopped paying for that conversion in this name specifically.

Life-cycle: SATURATED. Dating it: retail-facing five-year-return arithmetic recycled on 07-21 and again on 08-03; CNBC "Final Trades" mentions on 07-15 and 07-16; sell-side marking toward the tape rather than away from it (TD Cowen $230→$222 on 07-27, UBS $233→$227 on 07-28, BofA to $196 from $202); and a 52-week change of -32.55% as of 08-06. The 08-03 bounce widened no participation — it was reversed inside one session.

The 2026-08-07 release and 10:00 a.m. ET call is the only company-specific datapoint since 2026-05-07 and the last one dated before the PJM backstop window opens 09-30. It is also the weekly close.

Bullish and bearish views on Vistra Corp.

The model's bull view on Vistra Corp. (VST), in brief: A second 2026 capacity event is now docketed. The bear view: The last near-term shelf is gone. The 08-05 close of $140.58 is below the 07-29 low of $142.81. At $141.38 the stock sits 9.1% under a falling 50-day at $155.49 and 13.0% under the 200-day at $162.56. The weakness turned company-relative on 08-04. VST -8.15% versus CEG -2.36%… Both cases follow in full.

Bull Case

• A second 2026 capacity event is now docketed. PJM filed at FERC on 2026-07-31 (ER26-3380-000) to open a Reliability Backstop Procurement on 09-30 running to 10-21, targeting the 6,831 MW shortfall left by the 2028/29 Base Residual Auction. The 07-27 board decisional letter set the cost cap for accepted bids at $555/MW-day against the $325/MW-day cap at which the 07-14 auction cleared. Vistra's 2028 book was 65% hedged as of 2026-05-01 — the delivery year this touches is the one least sold forward.
• Two PJM-weighted peers raised numbers on the same demand curve this week. Talen raised its 2026 guide on 08-05; Constellation raised FY26 adjusted operating EPS to $11.50–12.50 on 08-06 and cited firmer PJM capacity prices and Calpine accretion. Vistra's East segment produced $801M of the $1,494M Q1 2026 Adjusted EBITDA.
• Guidance intact with the contracted layer still outside it. FY2026 Ongoing Operations Adjusted EBITDA of $6.8–7.6B and Adjusted FCFbG of $3.925–4.725B were reaffirmed 2026-05-07; the 2027 midpoint opportunity range of $7.4–7.8B excludes Cogentrix and the Meta PPAs.
• Hyperscaler contracting kept clearing in the same week. Constellation's ~920 MW of nuclear PPAs (08-06) and NRG's 1.2 GW Texas build-for-a-hyperscaler (08-04) are third-party evidence that large-load procurement is still being signed at scale.
• Multiple has compressed to the low end of the complex. Forward P/E 16.19, EV/EBITDA 10.32, market cap $47.67B at the 08-06 close, against a consensus average target of $222.74.
• Q2 is a growth quarter on either consensus track. Barchart carries $2.43 EPS, Investing.com $2.05, against $1.01 a year earlier, on revenue near $5.73B (+35% YoY).

Bear Case

• The last near-term shelf is gone. The 08-05 close of $140.58 is below the 07-29 low of $142.81. At $141.38 the stock sits 9.1% under a falling 50-day at $155.49 and 13.0% under the 200-day at $162.56.
• The weakness turned company-relative on 08-04. VST -8.15% versus CEG -2.36% and TLN -1.30% on a day with no Vistra release. Volume of 11.44M compares with 4.0–6.0M on the surrounding sessions.
• NRG priced what a merchant miss costs. Down 15.48% on a reaffirmed guide, with interest expense named as the driver — a line item that applies to any leveraged merchant generator.
• A raise did not hold a bid. Constellation closed 08-06 down 1.52% on the session it lifted FY26 guidance and disclosed 920 MW of new nuclear contracts.
• Targets are being cut toward the tape. TD Cowen $222 (07-27), UBS $227 (07-28), BofA $196 — the low published mark. Morgan Stanley's raise to $212 (07-28) and Scotiabank's $298 (07-15) are the exceptions.
• Contracted cash lands late. AWS Comanche Peak 1,200 MW deliveries begin Q4 2027 and reach full volume in 2032; Meta PJM contributions begin 2027. The 2026 book was 98% hedged as of 05-01.
• Pre-planned, and all of it above the current tape.
• Backstop eligibility is unresolved. The requirement that qualifying resources be operational by 2032-06-01 points at new supply; whether the existing fleet can bid is not settled.

Setup & Price Structure

Close 2026-08-06: $141.38, 6.6% above the $132.66 52-week low set in May, inside a $132.66–$219.82 annual range. Both major averages sit above price and are declining: 50-day $155.49, 200-day $162.56. Beta 1.43.

The week's path is the structure: $155.94 on 08-03 after a 5.23% group bounce, $143.23 on 08-04, $140.58 on 08-05, $141.38 on 08-06. The 08-03 high of $156.96 was rejected 0.3% under the 50-day, the same average that capped the June bounce. Nothing between the current close and $132.66 has been defended.

Crowding and positioning observables: short interest 12.60M shares, 4.01% of float, 2.93 days to cover — small enough that the drawdown reads as long-side supply rather than a squeeze setup. Consensus average target $222.74 against a $141.38 close is a 57% gap that widened by price falling while targets were cut. Retail-facing coverage stayed in backward-looking return arithmetic on 07-21 and 08-03 while the stock made new relative lows. The earnings date is not merely imminent — it is today, and it coincides with the weekly close.

Catalyst Calendar (next 30 days)

• 2026-08-14 — Q2 2026 13F deadline. First institutional-ownership read covering the June–July drawdown.
• Nothing else company-dated falls inside the 30-day window. The next scheduled item is 2026-09-30, when the PJM Reliability Backstop Procurement opens and runs to 10-21.

Elapsed catalysts

• 2026-08-07 — Q2 2026 results release and 10:00 a.m. ET conference call. First company-specific datapoint since 2026-05-07. (passed 2d ago)
• ~2026-08-07 (est.) — Form 10-Q filing. Updated 2027 and 2028 hedge percentages against the 89% and 65% marked as of 2026-05-01; buyback spend against roughly $1.5B of remaining authorization; Cogentrix closing language. (passed 2d ago)

What Would Change Our Mind

The last floor under this tape is the May low at $132.66. Everything above it has already been surrendered: the 50-day capped the 08-03 bounce at $156.96 intraday, and the 07-29 flush low of $142.81 was forfeited on the 08-05 close. A weekly close below $132.66 takes out the 52-week floor and leaves no reference level between the tape and untested price — the point at which a crowded narrative becomes a failed one.

The secondary break is calendar. A 2026-08-07 print that only reaffirms the $6.8–7.6B FY26 range, in the same week Talen and Constellation raised theirs, leaves nothing company-dated before 09-30 and frames Vistra as the slower monetizer on a demand curve its peers are already converting.

The repair case requires two things together, and they have not co-occurred since 06-18: a raise to the FY26 range, or the addition of Cogentrix or the Meta PPAs into the 2027 $7.4–7.8B opportunity range, alongside a weekly close back above the 50-day at $155.49. A post-print gap that fails to hold through the following week's close would repeat the 08-03 pattern.

Correlation Notes

• Dispersion on 08-04 was informative. NRG -15.48%, VST -8.15%, CEG -2.36%, TLN -1.30%. Vistra traded closer to NRG than to the nuclear pair, consistent with its ERCOT-and-retail weighting rather than a pure PJM capacity read.
• The 08-03 bounce was group beta. VST +5.23%, CEG +4.17%, NRG +3.48%, TLN +3.11%, with no company release at any of the four.
• The complex decoupled from the index. On 08-04 the S&P 500 set record highs with Palantir up 27% while the power names fell; the group is trading on its own factor.
• PJM capacity price is the shared variable. Constellation cited firmer PJM capacity in its raise; Talen cleared over 10 GW at the $325/MW-day cap in the 2028/29 auction; Vistra's East segment carried 54% of Q1 Adjusted EBITDA.
• Hyperscaler capex is the upstream input and it rose in July. Alphabet lifted FY26 capex to $195–205B on 07-22; Meta guided FY26 to $130–145B on 07-29. Those revisions moved the opposite direction from the power complex.
• Regulatory siting is the shared downside factor. New York's 2026-07-14 order pausing large data-center projects applies to the whole demand extrapolation rather than to any single generator.